# Evaluation of Carebot AI MMG Medical Device for Breast Lesion Detection and Density Assessment

> **NCT06428799** · — · COMPLETED · sponsor: **Carebot s.r.o.** · enrollment: 122 (actual)

## Conditions studied

- Breast Cancer
- Breast Tumor Benign

## Interventions

- **DEVICE:** Carebot AI MMG

## Key facts

- **NCT ID:** NCT06428799
- **Lead sponsor:** Carebot s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-14
- **Primary completion:** 2024-04-24
- **Final completion:** 2024-04-24
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06428799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06428799, "Evaluation of Carebot AI MMG Medical Device for Breast Lesion Detection and Density Assessment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06428799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*